AI-based Disease Identification

1 article · search the full text for this term

• Published Subscription Original Research 23 May 2025

  AI-based Drug Discovery-Revolutionizing Pharmaceutical Research

  By Nikhil Mangesh Patil, Suraj Vijay Magar, Usama Kasam Rinde, Pradhum Rajendra Biradar, Sonali Dheeraj Parab

  Abstract: The traditional drug discovery process is often costly, time-consuming, and prone to high failure rates. The advent of Artificial Intelligence (AI) has revolutionized this field by significantly enhancing efficiency, reducing costs, and improving success rates. AI-driven approaches, including machine learning (ML), deep learning (DL), and natural language processing (NLP), have transformed key areas such as drug target identification, molecular screening, lead optimization, and clinical trial design. AI models can analyze …

  Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 12, Issue 2, 2025 · pp. 30–44 Read article →